Trials / Completed
CompletedNCT02344875
Clinical Pharmacology of FYU-981 (Elder Subjects)
Clinical Pharmacological Study of FYU-981 Administered to Male and Female Elder or Non-elder Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Fuji Yakuhin Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the pharmacokinetics, safety and pharmacodynamics after single oral administration of FYU-981 to male and female elder subjects in comparison with non-elder subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | FYU-981, (Oral single dosing) |
Timeline
- Start date
- 2014-05-01
- Primary completion
- 2014-06-01
- Completion
- 2014-07-01
- First posted
- 2015-01-26
- Last updated
- 2015-01-26
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT02344875. Inclusion in this directory is not an endorsement.